BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities.
BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.
Ability to provide informed consent
Age 50 years or older
Self-identify as Black or African American
Diagnosis of Parkinson's Disease and/or neurological condition
Familial history of PD and/or neurodegenerative or psychiatric conditions
Unknown family history of PD and/or neurodegenerative or psychiatric conditions
Any conditions that, in the investigator's opinion, preclude the individual's ability to carry out study activities
Black Americans and African Americans with Parkinson's Disease or without a history of Parkinson's (control volunteers).
Case-control
Cross-sectional
Not listed
Explore novel risk factors and characterization
To explore novel risk factors and characterization of known genetic risk factors contributing to Parkinson's disease risk in the Black and African American population.
Click on the lead sponsor to view all of their trials.
Michael J. Fox Foundation for Parkinson's Research
Lead sponsor
University of Chicago
Collaborator
University of Alabama at Birmingham
Collaborator
Rush University
Collaborator
Washington University School of Medicine
Collaborator
Medical University of South Carolina
Collaborator
University Hospitals Cleveland Medical Center
Collaborator
Louisiana State University Health Sciences Center Shreveport
Collaborator
University of Florida
Collaborator
University of Maryland
Collaborator
The University of Texas Health Science Center, Houston
Collaborator
Ochsner Health System
Collaborator
Indiana University
Collaborator
